SCHEMBL632349

SCHEMBL632349

Clc1ccc(CNc2cccc(Cl)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.59
LMNA P02545 4/20 0.55
ALDH1A1 P00352 3/20 0.55
MAPT P10636 3/20 0.55
GAA P10253 1/20 0.51
KDM4E B2RXH2 1/20 0.51
PPARA Q07869 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
RAB9A P51151 2/20 0.50
RECQL P46063 1/20 0.50
MTOR P42345 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
HTT P42858 1/20 0.49
SCD O00767 1/20 0.48
MAOB P27338 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631634 0.89 LMNA (0.59) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL11935895 0.87 EGFR (0.52) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL27837422 0.87 MTOR (0.64) EGFRLMNAALDH1A1MAPTGAA
Hydrochloric Acid SCHEMBL7102271 0.87 LMNA (0.58) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL632217 0.86 CHRM2 (0.55) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL11513070 0.86 FFAR1 (0.57) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL11510373 0.85 GAA (0.51) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL6000282 0.84 ROCK2 (0.60) EGFRALDH1A1MAPTGAAKDM4E
SCHEMBL693227 0.84 KDM4E (0.48) EGFRLMNAALDH1A1MAPTGAA
SCHEMBL11511594 0.84 FFAR1 (0.50) EGFRLMNAALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586617-B2 Aminomethyl-4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
CN-101528710-B Aminomethyl-4-imidazoles HOFFMANN LA ROCHE 2012-11-07 CN disclosed
EP-2076497-B1 AMINOMETHYL-4-IMIDAZOLES HOFFMANN LA ROCHE (CH) 2012-02-22 EP disclosed
CN-101528710-A Aminomethyl-4-imidazoles HOFFMANN LA ROCHE (CH) 2009-09-09 CN disclosed
EP-2076497-A1 AMINOMETHYL-4-IMIDAZOLES F. Hoffmann-Roche AG (CH) 2009-07-08 EP disclosed
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-22 US disclosed
WO-2008046757-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed
US-4152452-A N-BENZYLANILINE AND DERIVATIVES WILLIAM H. RORER, INC. (US) 1979-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES INMT, HTR4, MC4R EGFR 2975/4885LMNA 3570/4885ALDH1A1 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.